Schooner Investment Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-5,000
Closed -$316K 3
2016
Q3
$316K Hold
5,000
1.25% 19
2016
Q2
$314K Sell
5,000
-2,500
-33% -$152K 0.77% 41
2016
Q1
$431K Hold
7,500
0.83% 40
2015
Q4
$432K Sell
7,500
-7,500
-50% -$432K 0.81% 41
2015
Q3
$827K Sell
15,000
-5,000
-25% -$325K 0.59% 41
2015
Q2
$1.37M Sell
20,000
-10,000
-33% -$653K 0.64% 36
2015
Q1
$1.71M Hold
30,000
0.61% 40
2014
Q4
$1.98M Sell
30,000
-20,000
-40% -$1.26M 0.52% 67
2014
Q3
$2.86M Sell
50,000
-25,000
-33% -$1.39M 0.67% 73
2014
Q2
$4.27M Buy
75,000
+5,000
+7% +$262K 0.96% 26
2014
Q1
$3.6M Buy
70,000
+55,000
+367% +$2.78M 0.9% 46
2013
Q4
$780K Sell
15,000
-44,500
-75% -$2.19M 0.24% 109
2013
Q3
$2.73M Buy
59,500
+6,500
+12% +$288K 0.99% 42
2013
Q2
$2.21M Buy
+53,000
New +$2.32M 0.99% 39

Other funds holding ABBV

Schooner Investment Group's ABBV Position: Q4 2016 in Review

Schooner Investment Group sold out of AbbVie (ABBV) in Q4 2016, closing a stake of 5,000 shares — an estimated $316K sold.

Schooner Investment Group first reported a position in ABBV in Q2 2013 and held it in 14 quarters. The position peaked at $4.27M in Q2 2014. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • Schooner Investment Group reported no remaining AbbVie position as of Q4 2016 after selling out during the quarter.
  • Schooner Investment Group sold 5,000 AbbVie shares in Q4 2016, an estimated $316K.
  • Schooner Investment Group first reported a position in AbbVie in Q2 2013 and held it in 14 quarters.
  • Schooner Investment Group's AbbVie position peaked at $4.27M in Q2 2014.
  • 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on Schooner Investment Group's 13F filing for Q4 2016, filed 13 Jan 2017.